News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,647 Results
Type
Article (87564)
Company Profile (827)
Press Release (775236)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233113)
Career Advice (4140)
Deals (39817)
Drug Delivery (141)
Drug Development (91293)
Employer Resources (203)
FDA (18302)
Job Trends (17407)
News (397519)
Policy (39932)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (133)
Alliances (56980)
ALS (147)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (269)
Approvals (18344)
Artificial intelligence (522)
Autoimmune disease (109)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (533)
Cancer (4238)
Cardiovascular disease (379)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (717)
Cervical cancer (33)
Clinical research (75953)
Collaboration (1462)
Company closure (4)
Compensation (982)
Complete response letters (64)
COVID-19 (2966)
CRISPR (87)
C-suite (632)
Cystic fibrosis (142)
Data (5113)
Decentralized trials (2)
Denatured (65)
Depression (116)
Diabetes (472)
Diagnostics (7116)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (249)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99502)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133709)
Executive appointments (1000)
FDA (20914)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (18)
Funding (1313)
Gene editing (184)
Generative AI (52)
Gene therapy (576)
GLP-1 (1050)
Government (5398)
Grass and pollen (8)
Guidances (375)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (263)
Immuno-oncology (22)
Indications (61)
Infectious disease (3220)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17933)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (13)
Lung cancer (600)
Lymphoma (290)
Machine learning (33)
Management (66)
Manufacturing (676)
MASH (152)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22806)
Metabolic disorders (1221)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (240)
Neuropsychiatric disorders (64)
Neuroscience (2783)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (587)
Opinion (317)
Ovarian cancer (146)
Pain (173)
Pancreatic cancer (183)
Parkinson's disease (248)
Partnered (32)
Patents (435)
Patient recruitment (346)
Peanut (57)
People (66382)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23426)
Phase II (32959)
Phase III (24856)
Pipeline (3074)
Policy (306)
Postmarket research (3554)
Preclinical (10592)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (718)
Real estate (7423)
Recruiting (79)
Regulatory (28175)
Reports (65)
Research institute (2700)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1071)
Venture capital (69)
Weight loss (414)
Women's health (63)
Worklife (21)
Date
Today (230)
Last 7 days (1333)
Last 30 days (3546)
Last 365 days (33622)
2025 (29183)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51104)
Australia (8983)
California (10108)
Canada (2968)
China (967)
Colorado (422)
Connecticut (447)
Delaware (290)
Europe (117495)
Florida (1478)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (834)
India (56)
Indiana (494)
Iowa (20)
Japan (340)
Kansas (127)
Kentucky (39)
Louisiana (27)
Maine (80)
Maryland (1341)
Massachusetts (7547)
Michigan (322)
Minnesota (594)
Mississippi (4)
Missouri (126)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (81)
New Jersey (2785)
New Mexico (32)
New York (2705)
North Carolina (1461)
North Dakota (10)
Northern California (4691)
Ohio (311)
Oklahoma (22)
Oregon (51)
Pennsylvania (2075)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3849)
Tennessee (153)
Texas (1572)
United States (36973)
Utah (301)
Virginia (258)
Washington D.C. (84)
Washington State (856)
West Virginia (4)
Wisconsin (105)
Wyoming (2)
There are 863,647 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Catalent’s Announced Cuts in Maryland This Year Now Total Over 400 Employees
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 10, 2025
·
78 min read
·
BioSpace Editorial Staff
Obesity
Despite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows
The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss drugs for patients, but knockoff versions of Zepbound and Wegovy still permeate the obesity market.
November 10, 2025
·
3 min read
·
Dan Samorodnitsky
Corsera Health
Corsera Health is redefining the future of health by enabling earlier prediction of atherosclerotic cardiovascular disease (ASCVD) and developing a once-annual RNAi medicine to prevent cumulative damage to the cardiovascular system.
Press Releases
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent portfolio; In addition, subsequent to quarter end, the Company received FDA approval to expand its pivotal clinical trial to the final stage, restarted enrollment, and successfully raised additional capital
November 10, 2025
·
15 min read
Press Releases
Theralase(R) Releases 3Q2025 Financial Statements
November 10, 2025
·
1 min read
Press Releases
acCELLerate Facilitates Custom Cell Banking Solutions for Pharmaceutical and Biotechnology Research with ATCC Authenticated Cell Lines
November 10, 2025
·
1 min read
Press Releases
Blood Cancer Diagnostics Market Size to Hit USD 21.42 Billion by 2034
November 10, 2025
·
1 min read
Press Releases
Infectious 20Disease 20In 20Vitro 20Diagnostics 20Market
November 10, 2025
·
1 min read
Gene therapy
Lilly Doubles Down on Eye Diseases, Adding to BD Spree
MeiraGTx Holdings is licensing a genetic eye disease medicine to Eli Lilly in a deal worth up to $475 million.
November 10, 2025
·
1 min read
·
Annalee Armstrong
Cardiovascular disease
Ionis’ Tryngolza ‘Game-Changing in Lowering Triglycerides, Cementing Case for FDA Filing
Ionis is planning a supplemental submission by the end of the year to expand Tryngolza into severe hypertriglyceridemia. If granted, William Blair expects the antisense drug to be “transformational” for this indication.
November 10, 2025
·
2 min read
·
Tristan Manalac
1 of 86,365
Next